Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors

Recruiting now

Conditions studied: Spinal Tumor

In brief

The purpose of this study was to compare efficacy and side effects of two target delineation methods for stereotactic radiotherapy of metastatic spinal tumors.

Key facts

Study ID

NCT06587022

Run by

Peking University Third Hospital

People needed

500

Starts

2017-01-01

Expected to finish

2027-12-30

Last updated by the study team

2024-09-19

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with spinal metastases or primary tumors receiving stereotactic radiotherapy;
• Patients with sufficent pre-treatment imaging data
• Patients who can cooperate with imaging review and follow-up after radiotherapy.

You may not qualify if…

• Patients with an expected survival of less than 3 months;
• Patients with second-course radiotherapy;
• Patients with physical conditions that cannot tolerate stereotactic radiotherapy;
• Patients with extensive spinal metastasis and no local therapeutic value

Where it is running

• Department of Radiation Oncology Cancer Center, Peking University Third Hospital 49# North Garden Rd.,Haidian Dist. — Beijing, Beijing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.